Home Biosimilar Antibodies GPCR & G Protein Others antibody Volagidemab (Anti-GCGR) For research use only.
Not for use in humans.

Volagidemab (Anti-GCGR)

Synonyms: REMD-477; AMG-477

Volagidemab (Anti-GCGR) is an antagonistic monoclonal antibody (mAb) that targets glucagon receptor (GCGR). Volagidemab can be used in the research of type 1 diabetes (T1D). MW: 145.5 KD.

Volagidemab (Anti-GCGR)

Purity & Quality Control

≥99

Biological Activity

Description Volagidemab (Anti-GCGR) is an antagonistic monoclonal antibody (mAb) that targets glucagon receptor (GCGR). Volagidemab can be used in the research of type 1 diabetes (T1D). MW: 145.5 KD.

Product Details

CAS No. 1233956-13-2
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Volagidemab (Anti-GCGR) | Volagidemab (Anti-GCGR) supplier | purchase Volagidemab (Anti-GCGR) | Volagidemab (Anti-GCGR) cost | Volagidemab (Anti-GCGR) manufacturer | order Volagidemab (Anti-GCGR) | Volagidemab (Anti-GCGR) distributor